A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune) Meeting Abstract
| Authors: | McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Wang, L.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Pili, R.; Runcie, K.; McHugh, D. J.; Offit, K.; Paller, C. J.; Haas, N. B.; Javier-Desloges, J.; Kane, C. J.; Seibert, T. M.; Bagrodia, A. |
| Abstract Title: | A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune) |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900562 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.TPS353 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS353 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work